Summary by Moomoo AI
George Simeon, associated with CRISPR Therapeutics AG [CRSP], engaged in a significant acquisition of the company's common stock on February 27, 2024. The transaction, which is currently in progress, involved the purchase of a total of 1,048,951 shares at a uniform price of $71.50 per share. Following these transactions, Simeon's holdings in CRISPR Therapeutics amount to 769,196 shares. The nature of the indirect beneficial ownership is detailed in notes associated with the transaction records.